Skip to main content

Obesity Therapy

  • Chapter
  • First Online:
Atlas of Diabetes
  • 3574 Accesses

Abstract

Obesity is defined as an excess of body fat. It is currently estimated that more than 1.5 billion people worldwide are overweight [1]. According to the National Health and Nutrition Examination Survey (NHANES), at least one-third of Americans are obese. Unfortunately, the tsunami of obesity led to the recent report that bariatric surgery has become the second most common abdominal operation in the USA [2]. These numbers should serve as a call to action for the implementation of obesity therapy in every primary care clinic and in most subspecialty clinics; endocrinology and diabetes care clinics are particularly important. In terms of obesity treatment, there are ample opportunities for secondary “prevention” of weight gain – in both overweight and obese patients – to keep obesity from getting worse, as well as treatment to reduce body weight and to improve health and well-being.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haslam DW, James WP: Obesity. Lancet 2005, 366:1197–1209.

    Article  PubMed  Google Scholar 

  2. Birkmeyer NJ, Dimick JB, Share D: Hospital complication rates with bariatric surgery in Michigan. JAMA 2010, 304:435–442.

    Article  PubMed  CAS  Google Scholar 

  3. Wang S, Sparks LM, Xie H: Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity. Int J Obes (Lond) 2009, 33:481–489.

    Article  CAS  Google Scholar 

  4. CDC: Vital signs: state-specific obesity prevalence among adults – United States, 2009. MMWR, 59:1–3.

    Google Scholar 

  5. Smith SR, Martin C, Katzmarzyk P, et al.: Obesity and diabetes: implications for management. In 2009 Educational Review Manual in Endocrinology FOCUS: Diabetes. Edited by Kendall, DM. New York: Castle Connolly Graduate Medical; 2009.

    Google Scholar 

  6. National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. Obes Res 1998, 6(Suppl 2):51S–209S.

    Google Scholar 

  7. Gordon-Larsen P, The NS, Adair LS: Longitudinal trends in obesity in the United States from adolescence to the third decade of life. Obesity (Silver Spring, MD) 2010, 18:1801–1804.

    Google Scholar 

  8. Prospective Studies Collaboration,Whitlock G, Lewington S, et al.: Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083–1096.

    Google Scholar 

  9. Willett WC, Manson JE, Stampfer MJ, et al.: Weight, weight change, and coronary heart disease in women. Risk within the ’normal’ weight range. JAMA 1995, 273:461–465.

    Google Scholar 

  10. Sharma AM, Padwal R: Obesity is a sign – over-eating is a symptom: an aetiological framework for the assessment and management of obesity. Obes Rev 2010, 11:362–370.

    Article  PubMed  CAS  Google Scholar 

  11. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.

    Article  PubMed  CAS  Google Scholar 

  12. Hamman RF, Wing RR, Edelstein SL, et al.: Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006, 29:2102–2107.

    Article  PubMed  Google Scholar 

  13. Anderson JW, Greenway FL, Fujioka K, et al.: Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obes Res 2002, 10:633–641.

    Article  PubMed  CAS  Google Scholar 

  14. Foster GD, Wadden TA, Vogt RA, Brewer G: What is a reasonable weight loss? Patients’ expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol 1997, 65:79–85.

    Article  PubMed  CAS  Google Scholar 

  15. Sharma AM, Kushner, RF: A proposed clinical staging system for obesity. Int J Obes (Lond) 2009, 33:289–295.

    Article  CAS  Google Scholar 

  16. Hall K: Mechanisms of metabolic fuel selection – modeling human metabolism and body weight change. IEEE Eng Med Biol Mag 2010, 29:36–41.

    Article  PubMed  Google Scholar 

  17. Catenacci VA, Ogden LG, Stuht J, et al.: Physical activity patterns in the National Weight Control Registry. Obesity (Silver Spring, MD) 2008, 16:153–161.

    Google Scholar 

  18. Butryn ML, Phelan S, Hill JO, Wing RR: Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity (Silver Spring, MD) 2007, 15:3091–3096.

    Google Scholar 

  19. Sarwer DB, von Sydow Green A, et al.: Behavior therapy for obesity: where are we now? Curr Opin Endocrinol Diabetes Obes 2009, 16:347–352.

    Article  PubMed  Google Scholar 

  20. West DS, DiLillo V, Bursac Z, et al.: Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007, 30:1081–1087.

    Article  PubMed  Google Scholar 

  21. Heymsfield SB, van Mierlo CA, van der Knaap HC , et al.: Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003, 27:537–549.

    Article  PubMed  CAS  Google Scholar 

  22. Gupta AK, Smith SR, Greenway FL, Bray GA: Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome. Diabetes Obes Metab 2009, 11:330–337.

    Article  PubMed  Google Scholar 

  23. Astrup A: Is cardiometabolic risk improved by weight-loss drugs? Lancet 2010, 376:567–568.

    Article  PubMed  Google Scholar 

  24. Sjöström L, Narbro K, Sjöström CD, et al.: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741–752.

    Article  PubMed  Google Scholar 

  25. James WP, Caterson ID, Coutinho W, et al.: Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010, 363:905–917.

    Article  PubMed  CAS  Google Scholar 

  26. Yanovski SZ, Yanovski JA: Obesity. N Engl J Med 2002, 346:591–602.

    Article  PubMed  CAS  Google Scholar 

  27. Munro JF, MacCuish AC, Wilson EM, Duncan LJ: Comparison of continuous and intermittent anorectic therapy in obesity. Br Med J 1968, 1:352–354.

    Article  PubMed  CAS  Google Scholar 

  28. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27:155–161.

    Article  PubMed  CAS  Google Scholar 

  29. Padwal R, Li SK, Lau DC: Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes Relat Metab Disord 2003, 27:1437–1446.

    Article  PubMed  CAS  Google Scholar 

  30. Wadden TA, Berkowitz RI, Womble LG, et al.: Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005, 353:2111–2120.

    Article  PubMed  CAS  Google Scholar 

  31. Astrup A, Toubro S: When, for whom and how to use sibutramine? Int J Obes Relat Metab Disord 2001, 25(Suppl 4):S2–S7.

    Article  PubMed  Google Scholar 

  32. Smith SR, Weissman NJ, Anderson CM, et al.: Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010, 363:245–256.

    Article  PubMed  CAS  Google Scholar 

  33. Bray GA, Hollander P, Klein S, et al.: A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003, 11:722–733.

    Article  PubMed  CAS  Google Scholar 

  34. Smith SR, Aronne LJ, Burns CM, et al.: Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care 2008, 31:1816–1823.

    Article  PubMed  Google Scholar 

  35. Smith SR, Blundell JE, Burns C, et al.: Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Am J Physiol Endocrinol Metab 2007, 293:E620–E627.

    Article  PubMed  CAS  Google Scholar 

  36. Astrup A, Rössner S, Van Gaal L, et al.: Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009, 374:1606–1616.

    Article  PubMed  CAS  Google Scholar 

  37. Aronne LJ, Halseth AE, Burns CM, et al.: Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. Obesity (Silver Spring, MD) 2010, 18:1739–1746.

    Google Scholar 

  38. Greenway FL, Dunayevich E, Tollefson G, et al.: Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J Clin Endocrinol Metab 2009, 94:4898–4906.

    Article  PubMed  CAS  Google Scholar 

  39. NIH conference: Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991, 115:956–961.

    Google Scholar 

  40. Thaler JP, Cummings DE: Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009, 150:2518–2525.

    Article  PubMed  CAS  Google Scholar 

  41. Buchwald H, Estok R, Fahrbach K, et al.: Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009, 122:248–256 e5.

    Google Scholar 

  42. Sjöström L, Gummesson A, Sjöström CD, et al.: Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009, 10:653–662.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

I would like to acknowledge the two people who taught me the most about obesity therapy, Professors George Bray and Frank Greenway; Corby Martin, who introduced me to the science of behavior modification; and Tim Church, who made exercise science interesting and pertinent to obesity and diabetes.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven R. Smith MD .

Editor information

Editors and Affiliations

Resources

Resources

The Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Available on the NHLBI Web site at www.nhlbi.nih.gov and http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Smith, S.R. (2012). Obesity Therapy. In: Skyler, J. (eds) Atlas of Diabetes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1028-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1028-7_15

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-1027-0

  • Online ISBN: 978-1-4614-1028-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics